The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Pregabalin for the treatment of fibromyalgia syndrome: Results of a randomized, double‐blind, placebo‐controlled trial
Open accessAbstract
Objective: Fibromyalgia syndrome (FMS) is characterized by widespread musculoskeletal pain and lowered pain threshold. Other prominent symptoms include disordered sleep and fatigue. FMS affects an estimated 2% of the population, predominantly women. This trial was designed to evaluate the efficacy and safety of pregabalin, a novel α 2‐δ ligand, for treatment of symptoms associated with FMS. Methods: This multicenter, double‐blind, 8‐week, randomized clinical trial compared the effects of placebo with those of 150, 300, and 450 mg/day pregabalin on pain, sleep, fatigue, and health‐related quality of life in 529 patients with FMS. The primary outcome variable was the comparison of end point mean pain scores, derived from daily diary ratings of pain intensity, between each of the pregabalin treatment groups and the placebo group. Results: Pregabalin at 450 mg/day significantly reduced the average severity of pain in the primary analysis compared with placebo (−0.93 on a 0–10 scale) (P ≤ 0.001), and significantly more patients in this group had ≥50% improvement in pain at the end point (29%, versus 13% in the placebo group; P = 0.003). Pregabalin at 300 and 450 mg/day was associated with significant improvements in sleep quality, fatigue, and global measures of change. Pregabalin at 450 mg/day improved several domains of health‐related quality of life. Dizziness and somnolence were the most frequent adverse events. Rates of discontinuation due to adverse events were similar across all 4 treatment groups. Conclusion: Pregabalin at 450 mg/day was efficacious for the treatment of FMS, reducing symptoms of pain, disturbed sleep, and fatigue compared with placebo. Pregabalin was well tolerated and improved global measures and health‐related quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Farrar, J. T., Young, J. P., LaMoreaux, L., Werth, J. L., & Poole, M. R. (2001) · Pain · doi:10.1016/s0304-3959(01)00349-9 · Cited by 5,808
Self-citationA sharper Bonferroni procedure for multiple tests of significance
HOCHBERG, Y. (1988) · Biometrika · doi:10.1093/biomet/75.4.800 · Cited by 4,829
The short-form McGill pain questionnaire
Melzack, R. (1987) · Pain · doi:10.1016/0304-3959(87)91074-8 · Cited by 4,368
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,416
Self-citationThe Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial
Dworkin, R. H., Corbin, A. E., Young, J. P., Sharma, U., LaMoreaux, L., Bockbrader, H., Garofalo, E. A., & Poole, R. M. (2003) · Neurology · doi:10.1212/01.wnl.0000055433.55136.55 · Cited by 768
Self-citation
Cited by
Morin, C. M., & Benca, R. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60750-2 · Cited by 976
Pregabalin for acute and chronic pain in adults
Moore, R. A., Straube, S., Wiffen, P. J., Derry, S., & McQuay, H. J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007076.pub2 · Cited by 762
EULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
Treatment of chronic non-cancer pain
Turk, D. C., Wilson, H. D., & Cahana, A. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60402-9 · Cited by 716
Taylor, C. P., Angelotti, T., & Fauman, E. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.09.008 · Cited by 565
Nijs, J., George, S. Z., Clauw, D. J., Fernández-de-las-Peñas, C., Kosek, E., Ickmans, K., Fernández-Carnero, J., Polli, A., Kapreli, E., Huysmans, E., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00032-1 · Cited by 521
Manchikanti, L. (2017) · Pain Physician · doi:10.36076/ppj.2017.s92 · Cited by 430
Minimal Clinically Important Difference in the Fibromyalgia Impact Questionnaire
BENNETT, R. M., BUSHMAKIN, A. G., CAPPELLERI, J. C., ZLATEVA, G., & SADOSKY, A. B. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.081090 · Cited by 407
Ca2+ channel α2δ ligands: novel modulators of neurotransmission
Dooley, D. J., Taylor, C. P., Donevan, S., & Feltner, D. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.006 · Cited by 387
Lee, Y. C., Nassikas, N. J., & Clauw, D. J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3306 · Cited by 377
Russell, J. I., Mease, P. J., Smith, T. R., Kajdasz, D. K., Wohlreich, M. M., Detke, M. J., Walker, D. J., Chappell, A. S., & Arnold, L. M. (2008) · Pain · doi:10.1016/j.pain.2008.02.024 · Cited by 367
Self-citationClauw, D. J. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.09.006 · Cited by 350
Pregabalin: Its Pharmacology and Use in Pain Management
Gajraj, N. M. (2007) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000287643.13410.5e · Cited by 343
Berger, A., Dukes, E., Martin, S., Edelsberg, J., & Oster, G. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01480.x · Cited by 338
Self-citationElevated insular glutamate in fibromyalgia is associated with experimental pain
Harris, R. E., Sundgren, P. C., Craig, A. D., Kirshenbaum, E., Sen, A., Napadow, V., & Clauw, D. J. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24849 · Cited by 328
Arnold, L. M., Goldenberg, D. L., Stanford, S. B., Lalonde, J. K., Sandhu, H. S., Keck, P. E., Welge, J. A., Bishop, F., Stanford, K. E., Hess, E. V., et al. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22457 · Cited by 329
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Ware, M. A., Fitzcharles, M.-A., Joseph, L., & Shir, Y. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c76f70 · Cited by 324
Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews
Kroenke, K., Krebs, E. E., & Bair, M. J. (2009) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.12.006 · Cited by 307
Russell, I. J., Perkins, A. T., Michalek, J. E., & Oxybate SXB‐26 Fibromyalgia Syndrome Study Group (2009) · Arthritis & Rheumatism · doi:10.1002/art.24142 · Cited by 302
Self-citationPassard, A., Attal, N., Benadhira, R., Brasseur, L., Saba, G., Sichere, P., Perrot, S., Januel, D., & Bouhassira, D. (2007) · Brain · doi:10.1093/brain/awm189 · Cited by 300
Arnold, L. M., Russell, I. J., Diri, E. W., Duan, W. R., Young, J. P., Sharma, U., Martin, S. A., Barrett, J. A., & Haig, G. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2008.03.013 · Cited by 277
Self-citationHoffman, D. L., & Dukes, E. M. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01638.x · Cited by 277
Nagakura, Y., Oe, T., Aoki, T., & Matsuoka, N. (2009) · Pain · doi:10.1016/j.pain.2009.05.024 · Cited by 256
Understanding fibromyalgia: lessons from the broader pain research community.
Williams, D. A., & Clauw, D. J. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.06.001 · Cited by 250
Häuser, W., Bernardy, K., Üçeyler, N., & Sommer, C. (2009) · Pain · doi:10.1016/j.pain.2009.05.014 · Cited by 243
Crofford, L. J., Mease, P. J., Simpson, S. L., Young, J. P., Martin, S. A., Haig, G. M., & Sharma, U. (2008) · Pain · doi:10.1016/j.pain.2008.02.027 · Cited by 236
Self-citationJensen, K. B., Kosek, E., Wicksell, R., Kemani, M., Olsson, G., Merle, J. V., Kadetoff, D., & Ingvar, M. (2012) · PAIN · doi:10.1016/j.pain.2012.04.010 · Cited by 230
Biology and therapy of fibromyalgia. Stress, the stress response system, and fibromyalgia
Martinez-Lavin, M. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2146 · Cited by 234
Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome
Häuser, W., Petzke, F., & Sommer, C. (2010) · The Journal of Pain · doi:10.1016/j.jpain.2010.01.002 · Cited by 216
Internet-enhanced management of fibromyalgia: A randomized controlled trial
Williams, D. A., Kuper, D., Segar, M., Mohan, N., Sheth, M., & Clauw, D. J. (2010) · Pain · doi:10.1016/j.pain.2010.08.034 · Cited by 210
Selvanathan, J., Pham, C., Nagappa, M., Peng, P. W. H., Englesakis, M., Espie, C. A., Morin, C. M., & Chung, F. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101460 · Cited by 206
Restorative sleep predicts the resolution of chronic widespread pain: Results from the EPIFUND study
Davies, K. A., Macfarlane, G. J., Nicholl, B. I., Dickens, C., Morriss, R., Ray, D., & McBeth, J. (2008) · Rheumatology · doi:10.1093/rheumatology/ken389 · Cited by 179
Biology and therapy of fibromyalgia. New therapies in fibromyalgia.
Arnold (2006) · Arthritis Research & Therapy · doi:10.1186/ar1971 · Cited by 145
Clinical manifestations and diagnosis of fibromyalgia
Bennett, R. M. (2009) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.05.009 · Cited by 138
Beyond pain in fibromyalgia: Insights into the symptom of fatigue
Vincent, A., Benzo, R. P., Whipple, M. O., McAllister, S. J., Erwin, P. J., & Saligan, L. N. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4395 · Cited by 133
Current and Emerging Pharmacotherapy for Fibromyalgia
Tzadok, R., & Ablin, J. N. (2020) · Pain Research and Management · doi:10.1155/2020/6541798 · Cited by 122
“However, compared to placebo, it was not found to significantly improve complaints of fatigue in some trials, and none of the trials indicated any improvement in depressive symptoms [20, 21, 53].”
ResultJuvenile fibromyalgia: current status of research and future developments
Kashikar-Zuck, S., & Ting, T. V. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.177 · Cited by 106
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-7020-4086-3.00033-3 · Cited by 86
Developments in the scientific and clinical understanding of fibromyalgia
Buskila, D. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2720 · Cited by 81
A meta-analysis of the efficacy of fibromyalgia treatment according to level of care
Garcia-Campayo, J., Magdalena, J., Magallón, R., Fernández-García, E., Salas, M., & Andrés, E. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2455 · Cited by 76
Fatigue in fibromyalgia: a conceptual model informed by patient interviews
Humphrey, L., Arbuckle, R., Mease, P., Williams, D. A., Samsoe, B. D., & Gilbert, C. (2010) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-11-216 · Cited by 68
Self-citationMoldofsky, H. (2009) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2009.05.008 · Cited by 59
Ang, D. C., Kaleth, A. S., Bigatti, S., Mazzuca, S., Saha, C., Hilligoss, J., Lengerich, M., & Bandy, R. (2011) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.08.014 · Cited by 51
Long-Term Safety, Tolerability, and Efficacy of Duloxetine in the Treatment of Fibromyalgia
Mease, P. J., Russell, I. J., Kajdasz, D. K., Wiltse, C. G., Detke, M. J., Wohlreich, M. M., Walker, D. J., & Chappell, A. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.11.001 · Cited by 54
Self-citationPregabalin: A Review of its Use in Fibromyalgia
Lyseng-Williamson, K. A., & Siddiqui, M. A. A. (2008) · Drugs · doi:10.2165/00003495-200868150-00009 · Cited by 50
Antidepressants in the treatment of fibromyalgia
Moret, C., & Briley, M. (2006) · Neuropsychiatric Disease and Treatment · doi:10.2147/nedt.2006.2.4.537 · Cited by 46
Berger, A., Sadosky, A., Dukes, E., Martin, S., Edelsberg, J., & Oster, G. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802316550 · Cited by 40
Self-citationFibromyalgia: A complex syndrome requiring a multidisciplinary approach
Spaeth, M., & Briley, M. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1030 · Cited by 36
“A double-blind, 8-week, randomised clinical trial (Crofford et al., 2005) compared 150, 300 and 450mg/day pregabalin with placebo on pain (derived from daily diary ratings of pain intensity), sleep, fatigue and health-related quality of life in 529 patients with fibromyalgia.”
Novel pharmacotherapy for fibromyalgia
Wood, P. B., Holman, A. J., & Jones, K. D. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.6.829 · Cited by 30
Arnold, L. M., McCarberg, B. H., Clair, A. G., Whalen, E., Thomas, N., Jorga, A., Pauer, L., Vissing, R., & Park, P. W. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1384691 · Cited by 27
“1008–149 [21] (Placebo, n = 96) 12-week (11-week, BID) 150 (n = 99) 75 150 150 150 150 150 150 150 150 150 300 (n = 112) 75 150 150 225 225 225 300 300 300 300 600 (n = 88) 75 150 225 300 400 500 600 600 600 600 1008–173 [22] (Placebo, n = 30) 12-week (11-week, BID) 150 (n = 34) 75 150 150 150 150 150 150 150 150 150…”
Assessment of Patients with Fibromyalgia Syndrome
Mease, P. J. (2008) · Journal of Musculoskeletal Pain · doi:10.1080/10582450801960347 · Cited by 20
Self-citation
Metadata
- Authors
- Crofford, L. J., Rowbotham, M. C., Mease, P. J., Russell, I. J., Dworkin, R. H., Corbin, A. E., Young, J. P., LaMoreaux, L. K., Martin, S. A., Sharma, U., & Pregabalin 1008‐105 Study Group
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-04
- Volume
- 52
- Issue
- 4
- Pages
- 1264-1273
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1992436256
- Cited by
- 654
- References
- 44
- FWCI
- 34.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.